Taiwan - Delayed Quote TWD

OK Biotech Co., Ltd. (4155.TW)

17.60
-0.10
(-0.56%)
At close: May 23 at 1:30:26 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,730,130
1,670,033
1,191,985
1,483,523
1,263,378
Cost of Revenue
1,391,794
1,394,378
995,101
1,138,565
1,076,552
Gross Profit
338,336
275,655
196,884
344,958
186,826
Operating Expense
257,134
235,180
195,119
204,821
176,977
Operating Income
81,202
40,475
1,765
140,137
9,849
Net Non Operating Interest Income Expense
-1,257
-134
-1,850
-8,256
-7,105
Pretax Income
117,164
127,110
8,026
175,594
46,140
Tax Provision
21,672
20,791
9,620
38,868
14,718
Net Income Common Stockholders
82,667
93,975
2,948
143,462
43,462
Diluted NI Available to Com Stockholders
82,667
93,975
2,948
143,462
43,462
Basic EPS
0.58
0.66
0.02
1.37
0.41
Diluted EPS
0.57
0.64
0.02
1.16
0.40
Basic Average Shares
143,113.77
142,754
128,237
104,955
106,598.35
Diluted Average Shares
145,265.52
146,410
128,403
130,234
121,200
Total Expenses
1,648,928
1,629,558
1,190,220
1,343,386
1,253,529
Net Income from Continuing & Discontinued Operation
82,667
93,975
2,948
143,462
43,462
Normalized Income
98,444.32
79,974.78
8,975.20
162,621.42
40,121.62
Interest Income
5,761
6,096
7,147
3,168
972
Interest Expense
7,018
6,230
8,997
11,424
8,077
Net Interest Income
-1,257
-134
-1,850
-8,256
-7,105
EBIT
124,182
133,340
17,023
187,018
54,217
EBITDA
200,049
205,762
92,570
254,900
110,099
Reconciled Cost of Revenue
1,391,794
1,394,378
995,101
1,138,565
1,076,552
Reconciled Depreciation
75,867
72,422
75,547
67,882
55,882
Net Income from Continuing Operation Net Minority Interest
82,667
93,975
2,948
143,462
43,462
Total Unusual Items Excluding Goodwill
-19,358
16,738
-7,534
-24,606
4,905
Total Unusual Items
-19,358
16,738
-7,534
-24,606
4,905
Normalized EBITDA
219,407
189,024
100,104
279,506
105,194
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3,580.68
2,737.78
-1,506.80
-5,446.58
1,564.62
12/31/2021 - 6/20/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4106.TW Wellell Inc.
23.30
+0.22%
 
4121.TWO Rossmax International Ltd.
15.95
-0.31%
 
6796.TW Medimaging Integrated Solution Inc.
79.20
+0.89%
 
6598.TW Applied BioCode Corporation
20.25
+0.50%
 
6861.TW InnoCare Optoelectronics Corporation
54.00
-2.00%
 
4161.TWO Bioptik Technology Incorporation
31.15
+0.16%
 
4736.TW TaiDoc Technology Corporation
129.00
-0.39%
 
6767.TWO Wiltrom Co., Ltd.
33.00
-2.37%
 
4188.TWO AmCad BioMed Corporation
15.40
+4.41%
 
1781.TWO Health & Life Co., Ltd.
15.00
0.00%